Phase 1 53 trials
Phase 1
NCT03400306 Nov 2021 ovarian cancer AbbVie
Withdrawn
No outcome recorded
Phase 1
NCT02831179 Dec 2017 → Feb 2019 VIPoma , Zollinger-Ellison syndrome , adrenal cortex carcinoma , cutaneous neuroendocrine carcinoma +10 Vanderbilt-Ingram Cancer Center
Withdrawn
No outcome recorded
Phase 1
NCT02723864 Aug 2017 → Dec 2020 neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT02631733 May 2017 → Nov 2019 cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT03061188 May 2017 → Mar 2018 T-cell non-Hodgkin lymphoma , high grade malignant neoplasm , mantle cell lymphoma Northwestern University
Completed
No outcome recorded
Phase 1
NCT02944396 Dec 2016 → Oct 2019 non-small cell lung carcinoma AbbVie
Completed
No outcome recorded
Phase 1
NCT03227016 Oct 2016 → May 2021 small cell lung carcinoma Central European Society for Anticancer Drug Research
Unknown
No outcome recorded
Phase 1
NCT02483104 Jul 2015 → Mar 2016 ovarian cancer AbbVie
Completed
No outcome recorded
Phase 1
NCT02210663 Jul 2014 → Jan 2016 cancer AbbVie
Completed
No outcome recorded
Phase 1
NCT02033551 Dec 2013 → Sep 2016 breast cancer , colorectal cancer , gastric cancer , lung cancer +1 AbbVie
Completed
No outcome recorded
Phase 1
NCT02009631 Nov 2013 → Dec 2014 breast cancer , colorectal cancer , gastric cancer , lung cancer +1 AbbVie
Completed
No outcome recorded
Phase 1
NCT01908478 Oct 2013 → Jul 2017 malignant pancreatic neoplasm Cedars-Sinai Medical Center
Completed
No outcome recorded
Phase 1
NCT01618357 Jul 2013 → Sep 2023 breast cancer Richard Zellars
Completed
No outcome recorded
Phase 1
NCT01853306 Mar 2013 → May 2017 hereditary breast carcinoma , hereditary neoplastic syndrome , ovarian serous adenocarcinoma AbbVie
Completed
No outcome recorded
Phase 1
NCT01749397 Dec 2012 → Oct 2017 fallopian tube cancer , primary peritoneal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01589419 Jun 2012 → Jan 2015 —
AbbVie
Completed
No outcome recorded
Phase 1
NCT01617928 May 2012 → Jul 2013 cancer AbbVie
Completed
No outcome recorded
Phase 1
NCT01477489 Jan 2012 → Oct 2014 breast cancer University of Michigan Rogel Cancer Center
Completed
No outcome recorded
Phase 1
NCT01434316 Nov 2011 → Mar 2023 overdue cancer National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01459380 Oct 2011 → Jun 2016 fallopian tube carcinoma , ovarian clear cell cystadenocarcinoma , ovarian endometrioid adenocarcinoma , ovarian seromucinous carcinoma +3 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01495351 Oct 2011 → Feb 2015 plasma cell myeloma AHS Cancer Control Alberta
Completed
No outcome recorded
Phase 1
NCT01419548 Jul → Nov 2011 neoplasm National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 1
NCT01366144 Jun 2011 → Nov 2017 overdue breast carcinoma , cancer of unknown primary site , carcinoma of esophagus , endometrial carcinoma +9 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01351909 May 2011 → Nov 2016 overdue breast carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01281852 Mar 2011 → Feb 2017 cervical adenosquamous carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01264432 Jan 2011 → Nov 2016 fallopian tube carcinoma , ovarian carcinoma , peritoneal carcinomatosis , primary peritoneal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01282333 Jan 2011 → Feb 2013 bladder transitional cell carcinoma , extrahepatic bile duct carcinoma , gallbladder carcinoma , non-small cell lung carcinoma +2 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT01281150 Jan 2011 → Apr 2015 estrogen-receptor positive breast cancer , female breast carcinoma , male breast carcinoma , triple-negative breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01251874 Nov 2010 → Sep 2024 overdue triple-negative breast carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01233505 Oct 2010 → Oct 2013 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , cancer of unknown primary site , female breast carcinoma +5 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT01104259 Jul 2010 → Feb 2015 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , male breast carcinoma , triple-negative breast carcinoma University of Washington
Completed
No outcome recorded
Phase 1
NCT01139970 Jun 2010 → Apr 2014 B-cell adult acute lymphocytic leukemia , B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) , T-cell adult acute lymphocytic leukemia , acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent +6 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01145430 Jun 2010 → May 2017 fallopian tube carcinoma , male breast carcinoma , ovarian carcinoma , primary peritoneal carcinoma +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01199224 Jun → Nov 2010 cancer AbbVie
Completed
No outcome recorded
Phase 1
NCT01154426 May 2010 → Oct 2013 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01085422 Apr 2010 → Jun 2011 prostate cancer AbbVie
Completed
No outcome recorded
Phase 1
NCT01123876 Mar 2010 → Jan 2015 gastric cancer AbbVie
Completed
No outcome recorded
Phase 1
NCT01063816 Jan 2010 → Aug 2016 neoplasm AbbVie
Completed
No outcome recorded
Phase 1
NCT00989651 Oct 2009 → Sep 2016 fallopian tube carcinosarcoma , fallopian tube clear cell adenocarcinoma , fallopian tube endometrioid adenocarcinoma , fallopian tube mucinous adenocarcinoma +11 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01017640 Oct 2009 → May 2016 neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00994071 Sep 2009 → Mar 2013 astrocytoma (excluding glioblastoma) , brain stem glioma , ependymoma , medulloblastoma +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00770471 Jul 2009 → Mar 2012 central nervous system neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
No outcome recorded
Phase 1
NCT00946335 Jul 2009 → Oct 2011 atypical teratoid rhabdoid tumor , benign meningioma , childhood brain stem glioma , childhood central nervous system germ cell tumor +18 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00892736 Apr 2009 → May 2017 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , basal-like breast carcinoma , fallopian tube carcinoma +4 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01445522 Dec 2008 → Jul 2012 lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00740805 Aug 2008 → Sep 2021 overdue primary organ-specific lymphoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT00576654 Mar 2008 → Jan 2020 metastatic malignant neoplasm , triple-negative breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00649207 Mar 2008 → Mar 2013 brain neoplasm , metastatic neoplasm AbbVie
Completed
No outcome recorded
Phase 1
NCT00588991 Feb 2008 → Nov 2016 acquired polycythemia vera , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +13 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00535119 Sep 2007 → Oct 2012 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , hereditary breast ovarian cancer syndrome , neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00553189 Aug 2007 → Feb 2008 cancer , lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00526617 Aug 2007 → Jun 2010 breast cancer , fallopian tube cancer , hepatocellular carcinoma , metastatic melanoma +2 AbbVie
Completed
No outcome recorded
Phase 1
NCT00387608 Jun 2006 → Feb 2008 cancer of unknown primary site , leukemia , lymphoma National Institutes of Health Clinical Center (CC)
Completed
No outcome recorded
Show 43 more trials Phase 1/2 12 trials
Phase 1/2
NCT02412371 Apr 2015 → Aug 2019 non-small cell lung carcinoma AbbVie
Terminated
No outcome recorded
Phase 1/2
NCT02289690 Oct 2014 → Apr 2019 small cell lung carcinoma AbbVie
Completed
No outcome recorded
Phase 1/2
NCT01690598 Nov 2012 → Jan 2015 ovarian carcinoma Vejle Hospital
Completed
No outcome recorded
Phase 1/2
NCT01711541 Oct 2012 → Feb 2018 head and neck squamous cell carcinoma , oropharyngeal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT01642251 Sep 2012 → Dec 2016 lung large cell carcinoma , small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT01514201 Feb 2012 → Mar 2018 anaplastic astrocytoma , brain stem glioma , fibrillary astrocytoma , giant cell glioblastoma +2 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT01472783 Nov 2011 → Jan 2016 malignant epithelial tumor of ovary Vejle Hospital
Completed
No outcome recorded
Phase 1/2
NCT01326702 Jul 2011 → Apr 2015 B-cell adult acute lymphocytic leukemia , Burkitt lymphoma , Hodgkin's lymphoma, mixed cellularity , MALT lymphoma +19 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT01386385 Jun 2011 → May 2019 overdue lung large cell carcinoma , minimally invasive lung adenocarcinoma , squamous cell lung carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT01489865 Jan 2011 → Dec 2018 malignant pancreatic neoplasm Georgetown University
Completed
No outcome recorded
Phase 1/2
NCT01026493 Jul 2010 → May 2014 central nervous system neoplasm Radiation Therapy Oncology Group
Completed
No outcome recorded
Phase 1/2
NCT01012817 Nov 2009 → Jan 2019 overdue fallopian tube carcinoma , metastatic malignant neoplasm , ovarian carcinoma , primary peritoneal carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Show 2 more trials Phase 2 27 trials
Phase 2
NCT03044795 Nov 2019 → Nov 2020 cancer University Medical Center Groningen
Withdrawn
No outcome recorded
Phase 2
NCT03581292 Nov 2018 → Mar 2023 overdue anaplastic astrocytoma , glioblastoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT03289910 Sep 2018 → May 2023 overdue acquired polycythemia vera , acute myeloid leukemia , atypical chronic myeloid leukemia, BCR-ABL1 negative , chronic myelomonocytic leukemia +2 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT03032614 Sep 2017 → Mar 2019 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , breast cancer , ovarian cancer The University of Texas Health Science Center at San Antonio
Withdrawn
No outcome recorded
Phase 2
NCT02921256 Jan 2017 → Apr 2020 rectum adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT02890355 Oct 2016 → May 2019 pancreatic adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT02595905 Sep 2016 → Jan 2025 hereditary breast carcinoma , metastatic malignant neoplasm in the brain , triple-negative breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT02860819 Aug 2016 → Nov 2020 testicular germ cell tumor National Cancer Institute, Slovakia
Completed
No outcome recorded
Phase 2
NCT02305758 Dec 2014 → Sep 2017 colorectal cancer AbbVie
Completed
No outcome recorded
Phase 2
NCT01827384 Jan 2014 → Jun 2021 cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01818063 Apr 2013 → Mar 2015 triple-negative breast carcinoma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Completed
No outcome recorded
Phase 2
NCT01657799 Oct 2012 → Jan 2015 non-small cell lung carcinoma AbbVie
Completed
No outcome recorded
Phase 2
NCT01638546 Jul 2012 → Jan 2017 overdue small cell lung carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT01585805 May 2012 → Dec 2024 overdue pancreatic adenocarcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT01540565 Apr 2012 → Jan 2018 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , fallopian tube carcinoma , ovarian carcinoma +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01576172 Mar 2012 → Oct 2019 castration-resistant prostate carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01560104 Feb 2012 → Sep 2014 non-small cell lung carcinoma AbbVie
Completed
No outcome recorded
Phase 2
NCT01506609 Jan 2012 → Dec 2018 breast cancer AbbVie
Completed
No outcome recorded
Phase 2
NCT01266447 Feb 2011 → Jan 2016 cervical adenosquamous carcinoma , cervical small cell carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01306032 Jan 2011 → Dec 2014 fallopian tube cancer , ovarian cancer , primary peritoneal carcinoma , serous adenocarcinoma +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01205828 Aug 2010 → Oct 2014 hepatocellular carcinoma Georgetown University
Terminated
No outcome recorded
Phase 2
NCT01193140 Jul 2010 → Nov 2011 —
Abbott
Completed
No outcome recorded
Phase 2
NCT01149083 Jun 2010 → Sep 2024 female breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01042379 Mar 2010 → Dec 2030 expected HER2 positive breast carcinoma , angiosarcoma , female breast carcinoma , hormone receptor-positive breast cancer +1 QuantumLeap Healthcare Collaborative
Recruiting
No outcome recorded
Phase 2
NCT01113957 Mar 2010 → Jun 2013 ovarian cancer AbbVie
Completed
No outcome recorded
Phase 2
NCT01009788 Nov 2009 → Sep 2012 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , breast cancer Steven J Isakoff, MD, PhD
Completed
No outcome recorded
Phase 2
NCT01051596 Sep 2009 → Jun 2013 colorectal cancer Georgetown University
Completed
No outcome recorded
Show 17 more trials Phase 2/3 1 trial
Phase 2/3
NCT02152982 Dec 2014 → Dec 2021 overdue gliosarcoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 3 4 trials
Phase 3
NCT02470585 Jul 2015 → May 2019 ovarian cancer AbbVie
Terminated
No outcome recorded
Phase 3
NCT02264990 Sep 2014 → Nov 2019 non-small cell lung carcinoma AbbVie
Completed
No outcome recorded
Phase 3
NCT02106546 Apr 2014 → Jan 2017 non-small cell squamous lung carcinoma AbbVie
Completed
No outcome recorded
Phase 3
NCT02163694 Apr 2014 → Apr 2019 breast cancer AbbVie
Completed
No outcome recorded
Phase not applicable 1 trial
— NCT02158507 Sep 2014 → Jul 2021 triple-negative breast carcinoma University of Alabama at Birmingham
Completed
No outcome recorded
Phase not stated 1 trial
— NCT02985658 — hereditary breast carcinoma , triple-negative breast carcinoma University of Washington
No longer available
No outcome recorded